{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:42:01Z","timestamp":1792773721381,"version":"4.5.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            LARP7 suppresses TGF-\n                            <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                            \/SMAD3\u2013driven fibrosis by sequestering CDK9, which inhibits SMAD3 T179 phosphorylation and profibrotic transcription.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            TGF-\n                            <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                            1 represses LARP7 expression in injured tubules, establishing a self-reinforcing loop that amplifies and sustains fibrogenic signaling.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Tubule-specific LARP7 restoration interrupts this vicious cycle, attenuates SMAD3 activity, and confers protection against kidney fibrosis\n                            <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      1\/SMAD3 signaling drives organ fibrosis, underscoring the need to identify its endogenous regulators for precision therapies. LARP7, a core component of the 7SK snRNP complex that sequesters cyclin-dependent kinase 9, has an unexplored role in kidney fibrosis and a potential interplay with TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 signaling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Single-cell and spatial transcriptomic analyses combined with immunostaining of human kidney biopsies were used to investigate the association between LARP7 and TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 signaling in patients with CKD.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      models evaluated the expression profile of LARP7 after insults and its contribution to TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 signaling and fibrosis postinjury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We demonstrated that LARP7, abundantly expressed in normal tubules, was downregulated in CKD patients and inversely correlated with TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 activation. This expression pattern was conserved across ischemic, toxic, and obstructive fibrosis models and recapitulated in TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      1\u2013treated tubular epithelial cells, indicating a general link between LARP7 downregulation and enhanced TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 signaling. Further loss-of-function and gain-of-function\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      studies confirmed that LARP7 acted as a specific disruptor of SMAD3 linker region (T179) phosphorylation\u2014an event that coincided with\n                      <jats:italic toggle=\"yes\">C<\/jats:italic>\n                      -terminal phosphorylation and amplified SMAD3 transcriptional activity. LARP7 mediated this by sequestering CDK9 within the 7SK snRNP, thereby preventing CDK9\u2013SMAD3 interaction and consequently inhibiting SMAD3 T179 phosphorylation and profibrotic transcription. TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      1 itself suppressed LARP7 expression, completing a self-reinforcing feedback loop that perpetuates TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3 signaling in injured tubular epithelial cells. Further\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      studies showed that tubule-specific\n                      <jats:italic toggle=\"yes\">Larp7<\/jats:italic>\n                      deletion exacerbated kidney fibrosis after ischemic injury, whereas its overexpression, either preventatively (prefibrosis in an obstructive model) or therapeutically (postfibrosis in ischemic and toxic models), attenuated functional decline and halted fibrotic progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings revealed tubular LARP7 as a key negative regulator of TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      \/SMAD3\u2013driven kidney fibrogenesis. Targeted overexpression of LARP7 in injured tubular epithelial cells attenuated TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      1\/SMAD3 signaling and conferred protection against postinjury fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001084","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:00:14Z","timestamp":1774627214000},"page":"1864-1879","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tubular La Ribonucleoprotein 7 Suppresses TGF-\u03b2\/SMAD3 Signaling and Attenuates Kidney Fibrogenesis"],"prefix":"10.1681","volume":"37","author":[{"given":"Ziyu","family":"Zhao","sequence":"first","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9441-5077","authenticated-orcid":false,"given":"Zhuoyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8974-2432","authenticated-orcid":false,"given":"Ansheng","family":"Cong","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1685-2692","authenticated-orcid":false,"given":"Zhijie","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1057-8817","authenticated-orcid":false,"given":"Zhichen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0846-4030","authenticated-orcid":false,"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-0582","authenticated-orcid":false,"given":"Zuoyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5566-1345","authenticated-orcid":false,"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanmei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanran","family":"Cai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-7418","authenticated-orcid":false,"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-6310","authenticated-orcid":false,"given":"Wei","family":"Cao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney and Urological Diseases, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"7835","key":"B1-20261023","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature."},{"key":"B2-20261023","doi-asserted-by":"crossref","first-page":"107245","DOI":"10.1016\/j.phrs.2024.107245","article-title":"The current landscape of antifibrotic therapy across different organs: a systematic approach","volume":"205","author":"Fuster-Martinez","year":"2024","journal-title":"Pharmacol Res."},{"issue":"5","key":"B3-20261023","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","article-title":"Advances and challenges in kidney fibrosis therapeutics","volume":"21","author":"Abbad","year":"2025","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"B4-20261023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther."},{"issue":"7","key":"B5-20261023","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","article-title":"Fibrosis: cross-organ biology and pathways to development of innovative drugs","volume":"24","author":"Rieder","year":"2025","journal-title":"Nat Rev Drug Discov."},{"issue":"12","key":"B6-20261023","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med."},{"issue":"7970","key":"B7-20261023","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature."},{"issue":"19","key":"B8-20261023","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell."},{"issue":"4","key":"B9-20261023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarcon","year":"2009","journal-title":"Cell."},{"issue":"6","key":"B10-20261023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol."},{"issue":"2","key":"B11-20261023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymthe.2023.12.009","article-title":"Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs","volume":"32","author":"Gu","year":"2024","journal-title":"Mol Ther."},{"issue":"12","key":"B12-20261023","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1101\/gad.2060811","article-title":"A smad action turnover switch operated by WW domain readers of a phosphoserine code","volume":"25","author":"Aragon","year":"2011","journal-title":"Genes Dev."},{"issue":"6","key":"B13-20261023","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/ki.2015.235","article-title":"The Smad3\/Smad4\/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction","volume":"88","author":"Qu","year":"2015","journal-title":"Kidney Int."},{"issue":"3","key":"B14-20261023","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2009.09.043","article-title":"Ubiquitin ligase Nedd4L targets activated Smad2\/3 to limit TGF-beta signaling","volume":"36","author":"Gao","year":"2009","journal-title":"Mol Cell."},{"issue":"4","key":"B15-20261023","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/molecules25040838","article-title":"P-TEFb as a promising therapeutic target","volume":"25","author":"Fujinaga","year":"2020","journal-title":"Molecules."},{"issue":"3","key":"B16-20261023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2015.51","article-title":"Renal fibrosis is not reduced by blocking transforming growth factor-beta signaling in matrix-producing interstitial cells","volume":"88","author":"Neelisetty","year":"2015","journal-title":"Kidney Int."},{"issue":"3","key":"B17-20261023","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2022.12.006","article-title":"P-TEFb: the master regulator of transcription elongation","volume":"83","author":"Fujinaga","year":"2023","journal-title":"Mol Cell."},{"issue":"20","key":"B18-20261023","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/CIRCULATIONAHA.120.050812","article-title":"LARP7 protects against heart failure by enhancing mitochondrial biogenesis","volume":"143","author":"Yu","year":"2021","journal-title":"Circulation."},{"issue":"8","key":"B19-20261023","doi-asserted-by":"crossref","first-page":"110038","DOI":"10.1016\/j.celrep.2021.110038","article-title":"LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity","volume":"37","author":"Yan","year":"2021","journal-title":"Cell Rep"},{"issue":"9","key":"B20-20261023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCRESAHA.121.319590","article-title":"LARP7 suppresses endothelial-to-mesenchymal transition by coupling with TRIM28","volume":"129","author":"Liang","year":"2021","journal-title":"Circ Res."},{"issue":"4","key":"B21-20261023","doi-asserted-by":"crossref","first-page":"107974","DOI":"10.1016\/j.celrep.2020.107974","article-title":"L ARP7 is a BRCA1 ubiquitinase substrate and regulates genome stability and tumorigenesis","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Rep."},{"issue":"6861","key":"B22-20261023","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/35104575","article-title":"The 7SK small nuclear RNA inhibits the CDK9\/cyclin T1 kinase to control transcription","volume":"414","author":"Yang","year":"2001","journal-title":"Nature."},{"issue":"5","key":"B23-20261023","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molcel.2008.01.003","article-title":"A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis","volume":"29","author":"He","year":"2008","journal-title":"Mol Cell."},{"issue":"4s","key":"B24-20261023","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"issue":"1","key":"B25-20261023","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41392-023-01402-x","article-title":"A kidney-brain neural circuit drives progressive kidney damage and heart failure","volume":"8","author":"Cao","year":"2023","journal-title":"Signal Transduct Target Ther."},{"issue":"1","key":"B26-20261023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1681\/ASN.0000000000000488","article-title":"Glycolysis in peritubular endothelial cells and microvascular rarefaction in CKD","volume":"36","author":"Huang","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B27-20261023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med."},{"issue":"5","key":"B28-20261023","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molcel.2020.01.002","article-title":"LARP7-Mediated U6 snRNA modification ensures splicing fidelity and spermatogenesis in mice","volume":"77","author":"Wang","year":"2020","journal-title":"Mol Cell."},{"issue":"7","key":"B29-20261023","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.ASN.0000016444.90348.50","article-title":"Epithelial-specific Cre\/lox recombination in the developing kidney and genitourinary tract","volume":"13","author":"Shao","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B30-20261023","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","article-title":"Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression","volume":"56","author":"Abedini","year":"2024","journal-title":"Nat Genet."},{"key":"B31-20261023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"B32-20261023","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/s41467-022-31772-9","article-title":"Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration","volume":"13","author":"Balzer","year":"2022","journal-title":"Nat Commun."},{"issue":"23","key":"B33-20261023","doi-asserted-by":"crossref","first-page":"34112","DOI":"10.18632\/oncotarget.8746","article-title":"Inhibition of PHLPP2\/cyclin D1 protein translation contributes to the tumor suppressive effect of NF\u03baB2 (p100)","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"B34-20261023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduction Targeted Ther."},{"issue":"9","key":"B35-20261023","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.7150\/thno.41502","article-title":"JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression","volume":"10","author":"Kim","year":"2020","journal-title":"Theranostics."},{"issue":"D1","key":"B36-20261023","doi-asserted-by":"crossref","first-page":"D673","DOI":"10.1093\/nar\/gkaf1223","article-title":"The reactome knowledgebase 2026","volume":"54","author":"Ragueneau","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"B37-20261023","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2019080797","article-title":"Dnmt3a and Dnmt3b-Decommissioned fetal enhancers are linked to kidney disease","volume":"31","author":"Guan","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B38-20261023","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2022.04.027","article-title":"Myeloid-derived growth factor deficiency exacerbates mitotic catastrophe of podocytes in glomerular disease","volume":"102","author":"Zhan","year":"2022","journal-title":"Kidney Int."},{"issue":"5","key":"B39-20261023","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat Med."},{"issue":"1","key":"B40-20261023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2004040339","article-title":"Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis","volume":"16","author":"Okada","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B41-20261023","doi-asserted-by":"crossref","first-page":"10728","DOI":"10.1038\/s41467-024-54475-9","article-title":"Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids","volume":"15","author":"Furusho","year":"2024","journal-title":"Nat Commun."},{"issue":"4","key":"B42-20261023","doi-asserted-by":"crossref","first-page":"101606","DOI":"10.1016\/j.omtm.2025.101606","article-title":"Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectors","volume":"33","author":"Peek","year":"2025","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"suppl 1","key":"B43-20261023","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2022-167203","article-title":"Safety, tolerability, pharmacokinetics (PK) and preliminary antitumor activity of the cyclin-dependent Kinase-9 (CDK9) inhibitor AZD4573 in relapsed\/refractory hematological malignancies: a phase 1 first-in-human study","volume":"140","author":"Brummendorf","year":"2022","journal-title":"Blood."},{"issue":"suppl 1","key":"B44-20261023","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1182\/blood-2022-165979","article-title":"Phase 1b\/2a study of AZD4573 (CDK9i) and acalabrutinib in patients with relapsed\/refractory diffuse large B-cell lymphoma (r\/r DLBCL): results from dose-escalation","volume":"140","author":"Strati","year":"2022","journal-title":"Blood"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:01:22Z","timestamp":1792771282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001084","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"2025-10-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}